Major bleeding and severe thrombocytopenia after combined heparin and abciximab-c7E3 Fab therapy

Eur J Vasc Endovasc Surg. 2003 Jan;25(1):85-7. doi: 10.1053/ejvs.2002.1757.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Abciximab
  • Antibodies, Monoclonal / adverse effects*
  • Drug Therapy, Combination
  • Femoral Artery / injuries*
  • Hematologic Agents / adverse effects*
  • Hemorrhage / chemically induced*
  • Hemorrhage / complications
  • Heparin / adverse effects*
  • Humans
  • Immunoglobulin Fab Fragments / adverse effects*
  • Intraoperative Complications / therapy*
  • Ischemia / surgery
  • Leg / blood supply
  • Male
  • Middle Aged
  • Platelet Transfusion
  • Thrombocytopenia / chemically induced*
  • Thrombocytopenia / complications
  • Vascular Surgical Procedures / adverse effects*

Substances

  • Antibodies, Monoclonal
  • Hematologic Agents
  • Immunoglobulin Fab Fragments
  • Heparin
  • Abciximab